» Download Public Reports
About 1 300 reports
- Country report
- March 2013
- 9 pages
... Are dietary supplements which are generally used to fill nutritional deficiencies in food and to prevent diseases india S nutritional supplement market is expected to more than double in the next four years ...
March 2013
... Related millennium development goals, fact neonatal and newborn health through factors such as sheet n 290. World health organization 2011 maternal physical and mental health, health 3. Aftab s, ara j, kazi s, deeba ...
April 2013
... Of activities aimed at promoting disease education and awareness as a part of comprehensive efforts to eliminate lymphatic filariasis. In addition, the group has formed partnerships with a wide range ...
March 2013
... Such as jakarta, denpasar, medan, malang, bandung, and surabaya, to treat people with rheumatoid arthritis, said head of medical affairs pt roche indonesia, arya wibitomo. Person quoted (s): dr. D. Srsono ...
March 2013
... New dialysis patients new dialysis patients projected new dialysis patients since 2003, diabetes accounted for > 50% of the primary renal disease of new dialysis ...
April 2013
... Exam cl At a mental health budget level of $3.50 Per capita (india), efficiency results from choice suggest funding the following conditions: Epilepsy Alcohol treatment Depression treatment ...
April 2013
... Or contraception for good family planning and avoidance of sti To strengthen antenatal care among teenagers in order to reduce complications eg anemia To encourage them to come for booking or check up ...
April 2013
... Med 2006;38:52-63 these features lead to type 2 diabetes and cardiovascular disease visceral obesity is associated with a cluster of metabolic abnormalities often described as the Metabolic syndrome ...
» Purchase Premium Reports
(From $ 75 - $ 6 995)
About 800 reports
- $ 6 995
- Industry report
- February 2013
- by Global Data
Protelos (Osteoporosis) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Protelos (Osteoporosis) - Forecast and Market Analysis to 2022?. ...
February 2013
$ 6 995
Forteo (Osteoporosis) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Forteo (Osteoporosis) - Forecast and Market Analysis to 2022?. ...
February 2013
$ 6 995
Reclast (Osteoporosis) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Reclast (Osteoporosis) - Forecast and Market Analysis to 2022?. ...
February 2013
$ 6 995
Odanacatib (Osteoporosis) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Odanacatib (Osteoporosis) - Forecast and Market Analysis ...
February 2013
$ 6 995
BA-058 (Osteoporosis) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?BA-058 (Osteoporosis) - Forecast and Market Analysis to 2022?. ...
February 2013
$ 6 995
Evista (Osteoporosis) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Evista (Osteoporosis) - Forecast and Market Analysis to 2022?. ...
February 2013
$ 6 995
Viviant/Combriza (Osteoporosis) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Viviant/Combriza (Osteoporosis) - Forecast and Market ...